ÂÜÀòÂÒÂ×

Meghan Miller has worked in various roles in the field of biomedical sciences since 2002. Meghan began their career as a Pre-IRTA Fellow in the Ronald M. Summers laboratory at the National Institutes of Health, Clinical Center. Miller then moved to the University of California, San Diego, where they served as a Pre-IRTA Fellow, PhD student in Biomedical Sciences and Pharmacology, and HHMI Med-into-Grad Fellow. In 2012, they joined Roche as a Discovery Project Leader, Rare Diseases, and was later promoted to Senior Project Leader and Head of Research, Rare Diseases. In 2019, Miller joined Skyhawk Therapeutics as the Director of Discovery Biology and Assoc. Director of Translational Biology, Neurobiology.

Meghan Miller obtained their BA in Mathematics from Colgate University between 1998 and 2002. Meghan then obtained their PhD in Biomedical Sciences, Pharmacology from the University of California, San Diego - School of Medicine between 2004 and 2010.